The Arthritis Society wishes to thank all of its partners who have made possible the success of the 3rd Quebec Forum on Arthritis. This event is part of the educational component of our mission. The financial and logistic support given by these companies is essential to allow us to offer the 1.1 million Quebecers who live with arthritis the information and help they need in their struggle against the disease.

Organization Partners

Arthritis Alliance of Canada

The Arthritis Alliance of Canada, formerly the Alliance for the Canadian Arthritis Program (ACAP), was formed in 2002. Its goal is to improve the lives of Canadians with arthritis. With more than 36 member organizations, the Arthritis Alliance brings together arthritis health care professionals, researchers, funding agencies, governments, voluntary sector agencies, industry and, most importantly, representatives from arthritis consumer organizations from across Canada. While each member organization continues its own work, the Alliance provides a central focus for national arthritis-related initiatives.

Québec Medical Association

The QMA is involved in the main issues affecting the health care system in Québec and the future of the medical profession in order to improve the practice of medicine for the benefit of the population. It plays a key role in the adoption of new ways of doing things and raising awareness of the situation in Québec outside the province. A partner of the Canadian Medical Association (CMA) and MD Financial Management, the QMA constitutes the official corporate link to the medical profession in Canada and offers products and services adapted to physicians.

Canadian Spondylitis Association

The Canadian Spondylitis Association’s mission is to be the leader in Canada providing support, education and advocacy for the Spondyloarthritis patient community. Spondyloarthritis diseases include Ankylosing Spondylitis, Psoriatic Arthritis and other related diseases including : Undifferentiated  Spondyloarthritis, Enteropathic Arthritis, Reactive Arthritis and Juvenile Onset Arthritis.

Regroupement québécois des maladies orphelines

The Regroupement québécois des maladies orphelines (Quebec Orphan Diseases Association; RQMO) brings together over twenty rare disease associations; individuals affected by these diseases; and caregivers. The main service offered by the RQMO is their Information and Resource Centre on Rare Diseases where anyone can access – on demand – reliable, official, and up-to-date information about any rare disease. The RQMO also shares general information about rare diseases.

Doctorate Partners


At Janssen, we are dedicated to addressing and solving some of the most important unmet medical needs of our time including inflammatory diseases, like arthritis. Driven by our commitment to patients, we bring innovative products, services and solutions to people throughout the world. Through an innovative partnership with The Arthritis Society, Janssen Inc. is committed to serving the arthritis community by supporting several of The Society’s important initiatives.


Pfizer, The Arthritis Society’s National Education Partner, is inspired by a single goal: your health. Since 1849, Pfizer has been dedicated to developing innovative medications to prevent and treat diseases. But we believe that to be truly healthy, it takes more than medication. That’s why Pfizer is also committed to promoting the many small things we can do to stay healthy.

Master Partners


Thanks to an educational grant from AbbVie, The Arthritis Society tackled the issue of musculoskeletal health in the workplace with the project aptly called “Fit for Work”. AbbVie’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases.


Amgen Canada applies science and innovation to help fight serious illness and dramatically improve people’s lives. Amgen Canada serves patients throughout Canada by delivering vital medicines to them. In addition, Amgen contributes to the development of new therapies or new uses for existing medicines in partnership with many of Canada’s leading health care, academic, research, government and patient organizations. Today, tens of thousands of Canadians use Amgen medicines every year, and thousands more are enrolling in Amgen clinical studies to deliver the next generation of innovation.

Bachelor Partners


Today’s Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships.

UCB Canada

We aspire to be the patient-centric global biopharmaceutical leader transforming the lives of people living with severe diseases. Connecting science in new ways: by integrating biology (bio) and chemistry (pharma), we can gain much deeper insights into disease pathways, including the complexities of severe diseases, as well as producing more potent, cost-effective drugs.

Gold Partners


Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.  Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.


Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Indiana, Lilly provides answers – through medicines and information – for some of the world’s most urgent medical needs. Eli Lilly Canada, headquartered in Toronto, Ontario, employs more than 500 people across the country.


Novartis Pharmaceuticals Canada Inc., a leader in the healthcare field, is committed to the discovery, development and marketing of innovative products to improve the well-being of all Canadians. In 2012, the company invested close to $100 million in research and development in Canada. Novartis Pharmaceuticals Canada Inc. employs more than 600 people in Canada.


From our approach to clinical trials for new drug therapies, to industry partnerships and community involvement, Roche Canada is a leader in providing pharmaceutical and diagnostic solutions that make a profound difference in people’s lives. Our innovative approach improves the effectiveness and efficiency of the healthcare system in the diagnosis, treatment and management of acute and long-term disease. Roche Canada employs approximately 1,000 people across the country, with its pharmaceuticals head office located in Mississauga, Ontario and diagnostics division based in Laval, Quebec. We serve a broad base of healthcare facilities and practitioners across the country, working in partnership with them to ensure that the diagnostics and therapies we deliver meet the medial needs of today and of the future.

Sanofi Canada

Sanofi Canada is the Canadian affiliate of Sanofi, one of the world’s leading healthcare companies and maker of Synvisc One®. As a leading healthcare partner, we provide medicines in several therapeutic areas, mainly diabetes, oncology and specialty care. Backed by decades of service to Canadian healthcare professionals and patients, we are partnering with our customers in the search for solutions to Canada’s healthcare challenges. These include innovative initiatives to promote the appropriate use of medicines, make healthcare more efficient and cost-effective, and help people better manage their health.

Silver Partners

Innovative Medicines Canada

Innovative Medicines Canada is the national voice of Canada’s innovative pharmaceutical industry. We advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members’ commitment to being valued partners in the Canadian healthcare system.

Bronze Partners


Founded in November 1972, FORMEDICA has, since the very beginning, concentrated its efforts in the development of a complete line of orthopedic products designed to reinforce the benefits of therapeutic treatments while helping to correct certain physiological traumas. Its mission is to offer superior high-quality products that meet the current and future expectations of consumers. Formedica gives 1.5% of its sales from Arthri-Form  products to The Arthritis Society.


VIÜ MEDIA is your one-stop partner for producing your corporate, promotional or event-based video. At VIÜ MEDIA, we guide you through all the steps of production as we have the necessary expertise in pre-production, production and post-production. We are able to offer this from experience working with various customers of well established businesses and organizations such as McDonald’s, Natrel, Investissement Québec and SMEs. We take the time to understand your needs and your goals so that you are confident the first time you contact VIÜ MEDIA ! Whether it’s your first video project or you are an experienced producer, VIÜ MEDIA’s team will meet your needs and will work with you closely so that your video project is a real success.